This symposium will discuss the shifting borderlines between medicines and other product both a continuing concern and an opportunity for all companies, and the role of clinical trials in establishing the best treatment of care using both drugs and devices. We will also identify regulatory issues related to safety, performance and effectiveness.

Learning Objectives:
Discuss the differences in global regulatory practices dealing with drug device combination
Identify the borderlines advantage in obtaining market access for their products
Explain the role of a clinical trial in establishing the best treatment of care using both drugs and devices.